Why Is Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Stock Down Today?

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) Summary

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is trading up +0.63% at $656.01, reflecting a positive shift in investor sentiment today. The stock opened at $658.29 and has moved between $654.05 and $667.50 so far.

Trading volume is 701789, which is 30% below its average, and the price action suggests buying interest.

Technically, REGN on the NASDAQ is trading above its 50-day moving average of $641.68 and below its 200-day moving average of $705.78, indicating short-term strength but long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns REGN a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of +4.46% in 1 month ($685.28), +24.60% in 1 year ($817.36), and +39.84% in 5 years ($917.37).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.